Varkevisser RDM, Sas T, Aanstoot HJ, Wolffenbuttel BHR, van der Klauw MM. Residual C-peptide is associated with new and persistent impaired awareness of hypoglycaemia in type 1 diabetes.
J Diabetes Complications 2024;
38:108893. [PMID:
39500130 DOI:
10.1016/j.jdiacomp.2024.108893]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/01/2024] [Revised: 10/13/2024] [Accepted: 10/18/2024] [Indexed: 11/26/2024]
Abstract
AIMS
To describe the change in impaired awareness of hypoglycaemia (IAH) over time and to identify factors associated with this change in the Dutch Type 1 Diabetes biomarkers cohort (NCT04977635).
METHODS
A prospective cohort of type 1 diabetes patients, with C-peptide <300 pmol/L, who had completed the Clarke questionnaire, to determine IAH status, at baseline and after 2 years. Changes in awareness status were defined and compares as follows: unchanged normal awareness (NAH) versus unchanged IAH, new IAH versus reversal of IAH. Multivariate logistic regression models were fitted using forward and backward stepwise selection using a 0.10 P-value cut-off, and stepwise backward selection using AIC criteria.
RESULTS
A total of 431 out of 611 participants were included. The baseline prevalence of IAH was 17 % and 20 % after 2 years. The incidence proportion of new IAH and reversal of IAH were, 9.5 % and 31 %, respectively. For every 2.7-fold increase in C-peptide, the odds of IAH decrease by 58 %. A 1-unit increase in BMI over the 2-year follow-up period is associated with a 5.27-fold increase in the odds of reversing IAH.
CONCLUSIONS
Higher C-peptide levels are protective against new IAH, and an increase in BMI over time is associated with the reversal of IAH.
Collapse